| 0.07 0.015 (27.04%) | 10-09 15:08 | |||||||||||||
|
|
| Short term |   |
|||
| Mid term |  |
|||
| Targets | 6-month : | 0.1 |
1-year : | 0.12 |
| Resists | First : | 0.09 |
Second : | 0.1 |
| Pivot price | 0.06  |
|||
| Supports | First : | 0.06 |
Second : | 0.04 |
| MAs | MA(5) : | 0.05 |
MA(20) : | 0.07 |
| MA(100) : | 0.08 |
MA(250) : | 0.1 |
|
| MACD | MACD : | -0.1 |
Signal : | -0.1 |
| %K %D | K(14,3) : | 25.9 |
D(3) : | 20.1 |
| RSI | RSI(14): 48.5 |
|||
| 52-week | High : | 0.2 | Low : | 0.04 |
Price has closed above its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and BEARISH in mid-long term.[ DYNT ] has closed below upper band by 47.3%. Bollinger Bands are 61.7% wider than normal. The large width of the bands suggest high volatility as compared to its normal range. The bands have been in this wide range for 2 days. This is a sign that the current trend might continue.
| If tomorrow: | Open lower | Open higher |
| High: | 0.06 - 0.06 | 0.06 - 0.06 |
| Low: | 0.05 - 0.05 | 0.05 - 0.05 |
| Close: | 0.05 - 0.06 | 0.06 - 0.06 |
Dynatronics Corporation, a medical device company, designs, manufactures, and sells physical therapy, rehabilitation, orthopedics, pain management, and athletic training products in the United States. Its orthopedic soft bracing products include cervical collars, shoulder immobilizers, arm slings, wrist and elbow supports, abdominal and lumbosacral supports, maternity supports, knee immobilizers and supports, ankle walkers and supports, plantar fasciitis splints, and cold therapy products. The company provides therapeutic modality devices comprising electrotherapy, ultrasound, phototherapy, therapeutic lasers, shortwave diathermy, radial pulse therapy, hot and cold therapy, compression therapy, and electrodes. It also offers power and manually operated treatment tables, mat platforms, work tables, parallel bars, training stairs, weight racks, treadmills, and other related equipment. In addition, the company provides clinical supplies, including exercise bands and tubings, lotions and gels, orthopedic bracings, paper products, and other related supplies. It markets its products under the Bird & Cronin, Solaris, Hausmann, Physician's Choice, and PROTEAM brands. The company sells its products to orthopedists, physical therapists, chiropractors, athletic trainers, sports medicine practitioners, clinics, and hospitals, as well as online. It also exports its products to approximately 30 countries. Dynatronics Corporation was founded in 1979 and is headquartered in Eagan, Minnesota.
Fri, 26 Sep 2025
Dynatronics Delays Annual Report Filing - TipRanks
Fri, 14 Feb 2025
Dynatronics Corporation (DYNT) reports earnings - qz.com
Wed, 10 Jul 2024
DYNT Stock Price and Chart — OTC:DYNT - TradingView
Mon, 15 Jan 2024
Dynatronics Corporation Announces Andrew Hulett as New Board Member - Yahoo Finance
Mon, 08 Jan 2024
Leixir Dental Laboratory Group Appoints John Krier as Chief Executive Officer - businesswire.com
Wed, 21 Jun 2023
Polarean Imaging Appoints Dr. Christopher von Jako As CEO - citybiz
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Outperform |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Outperform |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Underperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Underperform |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Underperform |
|
Exchange:
OTC
|
|
|
Sector:
Healthcare
|
|
|
Industry:
Medical - Devices
|
|
| Shares Out | 5 (M) |
| Shares Float | 2 (M) |
| Held by Insiders | 41.3 (%) |
| Held by Institutions | 8.5 (%) |
| Shares Short | 16 (K) |
| Shares Short P.Month | 14 (K) |
| EPS | -1.22 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 1.4 |
| Profit Margin | -13.1 % |
| Operating Margin | -7.5 % |
| Return on Assets (ttm) | -8.4 % |
| Return on Equity (ttm) | -25.8 % |
| Qtrly Rev. Growth | -17.2 % |
| Gross Profit (p.s.) | 0 |
| Sales Per Share | 6.32 |
| EBITDA (p.s.) | -0.52 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | -2 (M) |
| Levered Free Cash Flow | 0 (M) |
| PE Ratio | -0.06 |
| PEG Ratio | 0 |
| Price to Book value | 0.04 |
| Price to Sales | 0.01 |
| Price to Cash Flow | -0.2 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|